Trial Profile

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Jun 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ingenol disoxate (Primary)
Indications Actinic keratosis
Focus Registrational; Therapeutic Use
Sponsors LEO Pharma

Most Recent Events

03 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
20 Dec 2017 Status changed from active, no longer recruiting to completed.
22 Mar 2017 Planned End Date changed from 1 Aug 2017 to 1 Oct 2017.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com